or Try an Advanced Search...

    Combination Drugs Stocks List

    Symbol Grade Name % Change
    ABBV A AbbVie Inc. -0.16
    INVA C Innoviva, Inc. -1.53
    View As Page of Charts
    Related Industries: Biotechnology Drug Manufacturers - Major
    Related Stock Lists: Adalimumab Advanced Prostate Cancer Anemia Antero Asthma Atopic Dermatitis Autoimmune Disease Blood Cancers Chronic Idiopathic Constipation Chronic Obstructive Pulmonary Disease Constipation Corticosteroid Crohn's Disease Depressive Disorder Drugs Endometriosis Eye Care Products Fluticasone Genotype Glucocorticoids

    Related ETFs - A few ETFs which own one or more of the above listed Combination Drugs stocks.

    Symbol Grade Name Weight
    HDLB B ETRACS Monthly Pay 2xLeveraged US High Dividend Low Volatility ETN Series B due September 30, 2044 9.8
    BOTZ A Global X Robotics & Artificial Intelligence Thematic ETF 9.6
    MEDI D Harbor Health Care ETF 9.33
    PJP C PowerShares Dynamic Pharmaceuticals 9.15
    MEDX D Horizon Kinetics Medical ETF 8.78
    View all Combination Drugs ETFs...
    Compare ETFs
    Compare BOTZ to MEDX Compare HDLB to PJP Compare MEDI to PJP

        Combination Drugs Stocks Recent News

        Date Stock Title
        Nov 1 ABBV Bristol Myers Squibb Stock Gets Relative Strength Rating Upgrade
        Nov 1 ABBV Pharma Stock Roundup: MRK, PFE, ABBV, NVS, LLY's Q3 Earnings in Focus
        Nov 1 ABBV AbbVie Third Quarter 2024 Earnings: Revenues Beat Expectations, EPS Lags
        Nov 1 ABBV AbbVie and EvolveImmune Therapeutics sign oncology collaboration
        Nov 1 ABBV 5 Stocks That Recently Announced Dividend Hikes
        Nov 1 ABBV Regeneron battles Wall Street uncertainty; Madrigal extends fast launch of MASH drug
        Nov 1 ABBV Eli Lilly's Zepbound sales, Pfizer wants in on weight loss drugs, AbbVie's big deal: Pharma news round up
        Oct 31 ABBV AbbVie and EvolveImmune Therapeutics Announce Collaboration and Option-to-License Agreement to Develop Next-Generation Cancer Biotherapeutics
        Oct 31 ABBV AbbVie announces 2025 dividend increase of 5.8% to $1.64 from $1.55 per share
        Oct 31 ABBV 5 Dividend Stocks to Double Up on Right Now -- Plus Some Dividend ETFs
        Oct 31 ABBV AbbVie Inc (ABBV) Q3 2024 Earnings Call Highlights: Strong Growth in Ex-Humira Platform and ...
        Oct 31 ABBV Q3 2024 AbbVie Inc Earnings Call
        Oct 30 ABBV AbbVie: 3 Positives From The Earnings Report
        Oct 30 ABBV AbbVie Has A New Cash Cow As Humira Bows To Skyrizi In Third-Quarter Beat
        Oct 30 ABBV AbbVie Inc. (ABBV) Q3 2024 Earnings Call Transcript
        Oct 30 ABBV What’s behind AbbVie's Q3 revenue beat?
        Oct 30 ABBV AbbVie (ABBV) Q3 2024 Earnings Call Transcript
        Oct 30 ABBV AbbVie Trumps Q3 Earnings & Sales Estimates, Raises '24 EPS View
        Oct 30 ABBV Compared to Estimates, AbbVie (ABBV) Q3 Earnings: A Look at Key Metrics
        Oct 30 ABBV AbbVie Raises Full-Year Outlook Following Third-Quarter Beat
        Related Industries: Biotechnology Drug Manufacturers - Major
        Related Stock Lists: Adalimumab Advanced Prostate Cancer Anemia Antero Asthma Atopic Dermatitis Autoimmune Disease Blood Cancers Chronic Idiopathic Constipation Chronic Obstructive Pulmonary Disease Constipation Corticosteroid Crohn's Disease Depressive Disorder Drugs Endometriosis Eye Care Products Fluticasone Genotype Glucocorticoids
        Combination Drugs

        Combination drugs are medications that contain two or more active ingredients in a single dosage form. These drugs are used to treat a variety of conditions, such as high blood pressure, diabetes, and asthma. Combination drugs can be more effective than taking multiple medications, as they can reduce the number of pills a patient needs to take and may also reduce side effects.

        Browse All Tags